▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

BioNTech Se (NASDAQ: BNTX)

$106.06

(0.9%)

$0.90

Price as of October 7, 2025, 4:00 p.m. ET

BioNTech Se Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
BNTX	-12.74%	+22.20%	+4.09%	+652%
S&P	+17.88%	+94.80%	+14.27%	+129%

BioNTech Se Company Info

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

News & Analysis

The Fool has written over 300 articles on BioNTech Se.

Featured Article

Investing in Biotech Stocks in 2025

Keith Speights | Oct 3, 2025

Featured Article

Why BioNTech Stock Jumped by Nearly 4% on Wednesday

The company's push deeper into a hot new technology, plus good news from a top collaborator, put the shine on its equity.

Eric Volkman | Oct 1, 2025

Why BioNTech Stock Bumped Higher Today

Eric Volkman | Sep 22, 2025

Investors were cheered by two pieces of good news concerning the biotech's most famous product.

Why BioNTech Stock Sank by More Than 7% Today

Eric Volkman | Sep 12, 2025

The type of vaccine it's most famous for might be cast in a very unflattering light in the very near future..

Why BioNTech Stock Crushed the Market Today

Eric Volkman | Sep 5, 2025

The company might be close to commercializing its most advanced pipeline program.

Investing in Vaccine Stocks

Keith Speights | Sep 1, 2025

Learn about the companies that are manufacturing vaccines and what you should know before investing in vaccine stocks.

Why BioNTech Stock Soared Today

Rich Smith | Jun 2, 2025

Bristol Myers Squibb just agreed to shower BioNTech with cash.

Why BioNTech Stock Got Trounced on Tuesday

Eric Volkman | May 6, 2025

Valuation

Earnings Transcripts

BioNTech Se (BNTX) Q4 2024 Earnings Call Transcript

BNTX earnings call for the period ending December 31, 2024.

Motley Fool Transcribing | Mar 10, 2025

BioNTech Se (BNTX) Q3 2024 Earnings Call Transcript

BNTX earnings call for the period ending September 30, 2024.

Motley Fool Transcribing | Nov 4, 2024

BioNTech Se (BNTX) Q2 2024 Earnings Call Transcript

BNTX earnings call for the period ending June 30, 2024.

Motley Fool Transcribing | Aug 5, 2024

BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript

BNTX earnings call for the period ending March 31, 2024.

Motley Fool Transcribing | May 6, 2024

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services